{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:58:39Z","timestamp":1791845919788,"version":"4.3.4"},"reference-count":187,"publisher":"Elsevier BV","issue":"6","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.semcancer.2013.09.004","type":"journal-article","created":{"date-parts":[[2013,9,30]],"date-time":"2013-09-30T19:01:34Z","timestamp":1380567694000},"page":"431-440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"special_numbering":"PA","title":["Marginal zone lymphomas and infectious agents"],"prefix":"10.1016","volume":"23","author":[{"given":"Andr\u00e9s J.M.","family":"Ferreri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Govi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurilio","family":"Ponzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcancer.2013.09.004_bib0005","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1182\/asheducation-2009.1.523","article-title":"The 2008 WHO classification of lymphomas: implications for clinical practice and translational research","author":"Jaffe","year":"2009","journal-title":"Hematol Am Soc Hematol Educ Prog"},{"issue":"3","key":"10.1016\/j.semcancer.2013.09.004_bib0010","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1182\/blood.V95.3.802.003k19_802_806","article-title":"Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed","volume":"95","author":"Thieblemont","year":"2000","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.semcancer.2013.09.004_bib0015","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/jnci\/djh102","article-title":"Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas","volume":"96","author":"Ferreri","year":"2004","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"10.1016\/j.semcancer.2013.09.004_bib0020","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/00000478-200009000-00012","article-title":"Primary cutaneous B-cell lymphoma and Borrelia burgdorferi infection in patients from the Highlands of Scotland","volume":"24","author":"Goodlad","year":"2000","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.semcancer.2013.09.004_bib0025","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0002-9440(10)61691-4","article-title":"Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma","volume":"159","author":"Marasca","year":"2001","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.semcancer.2013.09.004_bib0030","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/annonc\/mdl388","article-title":"Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT","volume":"18","author":"Arcaini","year":"2007","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.semcancer.2013.09.004_bib0035","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/sj.thj.6200195","article-title":"A prospective phase II clinical trial with the use of zidovudine and interferon-alpha in the acute and lymphoma forms of adult T-cell leukemia\/lymphoma","volume":"3","author":"Hermine","year":"2002","journal-title":"Hematol J"},{"issue":"8797","key":"10.1016\/j.semcancer.2013.09.004_bib0040","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/0140-6736(92)90280-G","article-title":"High incidence of primary gastric lymphoma in northeastern Italy","volume":"339","author":"Doglioni","year":"1992","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.semcancer.2013.09.004_bib0045","first-page":"60","article-title":"Gastric adenocarcinoma and Helicobacter pylori infection","volume":"161","author":"Parsonnet","year":"1994","journal-title":"West J Med"},{"issue":"1","key":"10.1016\/j.semcancer.2013.09.004_bib0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-2141.1998.00513.x","article-title":"B-cell lymphoma of MALT type: a review with special emphasis on diagnostic and management problems of low-grade gastric tumours","volume":"100","author":"Zucca","year":"1998","journal-title":"Br J Haematol"},{"issue":"Suppl.","key":"10.1016\/j.semcancer.2013.09.004_bib0055","first-page":"335A","article-title":"Regression of low grade B-cell gastric lymphoma of MALT type following eradication of Helicobacter pylori (meeting abstract)","volume":"170","author":"Wotherspoon","year":"1993","journal-title":"J Pathol"},{"issue":"3","key":"10.1016\/j.semcancer.2013.09.004_bib0060","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1182\/blood-2005-01-0004","article-title":"Nuclear expression of BCL10 or nuclear factor kappa B helps predict Helicobacter pylori-independent status of low-grade gastric mucosa-associated lymphoid tissue lymphomas with or without t(11;18)(q21;q21)","volume":"106","author":"Yeh","year":"2005","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.semcancer.2013.09.004_bib0065","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1111\/j.1572-0241.2001.04036.x","article-title":"Helicobacter pylori and gastric lymphoma: high seroprevalence of CagA in diffuse large B-cell lymphoma but not in low-grade lymphoma of mucosa-associated lymphoid tissue type","volume":"96","author":"Delchier","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.semcancer.2013.09.004_bib0070","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1182\/blood-2002-12-3803","article-title":"Gastric marginal zone lymphoma is associated with polymorphisms in genes involved in inflammatory response and antioxidative capacity","volume":"102","author":"Rollinson","year":"2003","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.semcancer.2013.09.004_bib0075","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.3748\/wjg.v10.i16.2334","article-title":"Helicobacter pylori enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in human gastric epithelial cells","volume":"10","author":"Wu","year":"2004","journal-title":"World J Gastroenterol"},{"issue":"9","key":"10.1016\/j.semcancer.2013.09.004_bib0080","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1182\/blood-2004-05-1792","article-title":"IL-1 gene cluster polymorphisms and development of primary gastric B-cell lymphoma in Helicobacter pylori infection","volume":"104","author":"Hellmig","year":"2004","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.semcancer.2013.09.004_bib0085","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1572-0241.2002.05460.x","article-title":"Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome","volume":"97","author":"Levy","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.semcancer.2013.09.004_bib0090","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1128\/JCM.41.1.397-402.2003","article-title":"Real-time PCR assay for rapid and accurate detection of point mutations conferring resistance to clarithromycin in Helicobacter pylori","volume":"41","author":"Oleastro","year":"2003","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.semcancer.2013.09.004_bib0095","first-page":"218","article-title":"Clinical staging classification of non-Hodgkin's lymphomas (author's transl)","volume":"153","author":"Musshoff","year":"1977","journal-title":"Strahlentherapie"},{"issue":"May (5)","key":"10.1016\/j.semcancer.2013.09.004_bib0100","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/oxfordjournals.annonc.a058869","article-title":"Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma","volume":"5","author":"Rohatiner","year":"1994","journal-title":"Ann Oncol"},{"issue":"8","key":"10.1016\/j.semcancer.2013.09.004_bib0105","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.revmed.2004.02.002","article-title":"MALT gastric lymphomas","volume":"25","author":"Ruskone-Fourmestraux","year":"2004","journal-title":"Rev Med Interne"},{"issue":"5","key":"10.1016\/j.semcancer.2013.09.004_bib0110","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1365-2559.2012.04289.x","article-title":"IRTA1 is selectively expressed in nodal and extranodal marginal zone lymphomas","volume":"61","author":"Falini","year":"2012","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.semcancer.2013.09.004_bib0115","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3960\/jslrt.47.31","article-title":"MALT lymphoma recent advances in aetiology and molecular genetics","volume":"47","author":"Du","year":"2007","journal-title":"J Clin Exp Hematopathol"},{"issue":"5","key":"10.1016\/j.semcancer.2013.09.004_bib0120","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1053\/gast.2002.33047","article-title":"T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication","volume":"122","author":"Liu","year":"2002","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.semcancer.2013.09.004_bib0125","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2141.2006.05969.x","article-title":"Distinct comparative genomic hybridisation profiles in gastric mucosa-associated lymphoid tissue lymphomas with and without t(11;18)(q21;q21)","volume":"133","author":"Zhou","year":"2006","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.semcancer.2013.09.004_bib0130","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1572-0241.2007.01521.x","article-title":"Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status","volume":"103","author":"Nakamura","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.semcancer.2013.09.004_bib0135","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/sj.leu.2403644","article-title":"T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma","volume":"19","author":"Streubel","year":"2005","journal-title":"Leukemia"},{"issue":"8871","key":"10.1016\/j.semcancer.2013.09.004_bib0140","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0140-6736(93)91408-E","article-title":"The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori","volume":"342","author":"Hussell","year":"1993","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.semcancer.2013.09.004_bib0145","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0016-5085(99)70395-1","article-title":"Impaired T-cell regulation of B-cell growth in Helicobacter pylori-related gastric low-grade MALT lymphoma","volume":"117","author":"D\u2019Elios","year":"1999","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.semcancer.2013.09.004_bib0150","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1053\/j.gastro.2007.02.031","article-title":"Inhibition of T-cell proliferation by Helicobacter pylori gamma-glutamyl transpeptidase","volume":"132","author":"Schmees","year":"2007","journal-title":"Gastroenterology"},{"issue":"21","key":"10.1016\/j.semcancer.2013.09.004_bib0155","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1200\/JCO.2005.05.5434","article-title":"Association of T-cell regulatory gene polymorphisms with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma","volume":"24","author":"Cheng","year":"2006","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.semcancer.2013.09.004_bib0160","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ccr.2005.04.012","article-title":"Constitutive NF-kappaB activation by the t(11;18)(q21;q21) product in MALT lymphoma is linked to deregulated ubiquitin ligase activity","volume":"7","author":"Zhou","year":"2005","journal-title":"Cancer Cell"},{"issue":"22","key":"10.1016\/j.semcancer.2013.09.004_bib0165","doi-asserted-by":"crossref","first-page":"19012","DOI":"10.1074\/jbc.M009984200","article-title":"Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway","volume":"276","author":"Lucas","year":"2001","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.semcancer.2013.09.004_bib0170","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/annonc\/mds643","article-title":"ESMO Consensus conferences: guidelines on malignant lymphoma. Part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma","volume":"24","author":"Dreyling","year":"2013","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.semcancer.2013.09.004_bib0175","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/bjh.12078","article-title":"Gela histological scoring system for post-treatment biopsies of patients with gastric MALT lymphoma is feasible and reliable in routine practice","volume":"160","author":"Copie-Bergman","year":"2013","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.semcancer.2013.09.004_bib0180","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2141.2008.07486.x","article-title":"Chlorambucil versus observation after anti-Helicobacter therapy in gastric MALT lymphomas: results of the international randomised LY03 trial","volume":"144","author":"Hancock","year":"2009","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.semcancer.2013.09.004_bib0185","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1136\/gut.2006.096420","article-title":"Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series","volume":"56","author":"Fischbach","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.semcancer.2013.09.004_bib0190","series-title":"MALT lymphoma pathology, initial diagnosis, and posttreatment evaluation","author":"Copie-Bergman","year":"2008"},{"issue":"8","key":"10.1016\/j.semcancer.2013.09.004_bib0195","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/annonc\/mdi242","article-title":"Metachronous gastric MALT lymphoma and early gastric cancer: is residual lymphoma a risk factor for the development of gastric carcinoma?","volume":"16","author":"Copie-Bergman","year":"2005","journal-title":"Ann Oncol"},{"issue":"May (5)","key":"10.1016\/j.semcancer.2013.09.004_bib0200","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/gut.2005.083022","article-title":"Successful antibiotic treatment of Helicobacter pylori negative gastric mucosa associated lymphoid tissue lymphomas","volume":"55","author":"Raderer","year":"2006","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.semcancer.2013.09.004_bib0205","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/lary.20258","article-title":"Parotid mucosa-associated lymphoid tissue lymphoma regression after Helicobacter pylori eradication","volume":"119","author":"Iwai","year":"2009","journal-title":"Laryngoscope"},{"issue":"2","key":"10.1016\/j.semcancer.2013.09.004_bib0210","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1053\/gast.2003.50043","article-title":"Consecutive regression of concurrent laryngeal and gastric MALT lymphoma after anti-Helicobacter pylori therapy","volume":"124","author":"Caletti","year":"2003","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.semcancer.2013.09.004_bib0215","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1046\/j.1365-2141.2003.04170.x","article-title":"Extragastric mucosa-associated lymphoid tissue lymphoma showing the regression by Helicobacter pylori eradication therapy","volume":"120","author":"Arima","year":"2003","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1016\/j.semcancer.2013.09.004_bib0220","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1200\/JCO.2005.02.9025","article-title":"Antibiotic treatment is not effective in patients infected with Helicobacter pylori suffering from extragastric MALT lymphoma","volume":"24","author":"Grunberger","year":"2006","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.semcancer.2013.09.004_bib0225","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/hon.768","article-title":"Association between Helicobacter pylori infection and MALT-type lymphoma of the ocular adnexa: clinical and therapeutic implications","volume":"24","author":"Ferreri","year":"2006","journal-title":"Hematol Oncol"},{"issue":"26","key":"10.1016\/j.semcancer.2013.09.004_bib0230","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1200\/JCO.2005.05.018","article-title":"State-of-the-art therapeutics: marginal-zone lymphoma","volume":"23","author":"Bertoni","year":"2005","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.semcancer.2013.09.004_bib0235","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1365-2141.2006.06444.x","article-title":"Primary gastric lymphoma pathogenesis and treatment: what has changed over the past 10 years?","volume":"136","author":"Ferrucci","year":"2007","journal-title":"Br J Haematol"},{"issue":"22","key":"10.1016\/j.semcancer.2013.09.004_bib0240","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1200\/JCO.2005.05.660","article-title":"Prognostic value of translocation t(11;18) in tumoral response of low-grade gastric lymphoma of mucosa-associated lymphoid tissue type to oral chemotherapy","volume":"23","author":"Levy","year":"2005","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.semcancer.2013.09.004_bib0245","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/annonc\/mdl126","article-title":"Prolonged clinical remission in patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type treated with cladribine: 6 year follow-up of a phase II trial","volume":"17","author":"Jager","year":"2006","journal-title":"Ann Oncol"},{"issue":"33","key":"10.1016\/j.semcancer.2013.09.004_bib0250","doi-asserted-by":"crossref","first-page":"8442","DOI":"10.1200\/JCO.2004.00.8532","article-title":"Phase II study of oxaliplatin for treatment of patients with mucosa-associated lymphoid tissue lymphoma","volume":"23","author":"Raderer","year":"2005","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.semcancer.2013.09.004_bib0255","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/annonc\/mdq416","article-title":"Clinical activity of bortezomib in relapsed\/refractory MALT lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group (IELSG)","volume":"22","author":"Conconi","year":"2011","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.semcancer.2013.09.004_bib0260","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.leukres.2011.10.024","article-title":"Clinical experience of bendamustine treatment for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Spain","volume":"36","author":"Sanchez-Gonzalez","year":"2012","journal-title":"Leuk Res"},{"issue":"3","key":"10.1016\/j.semcancer.2013.09.004_bib0265","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3324\/haematol.2012.065995","article-title":"A phase II study of lenalidomide in patients with extranodal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT lymphoma)","volume":"98","author":"Kiesewetter","year":"2013","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.semcancer.2013.09.004_bib0270","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/annonc\/mdp349","article-title":"Absence of efficacy of thalidomide monotherapy in patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma)","volume":"20","author":"Troch","year":"2009","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.semcancer.2013.09.004_bib0275","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1200\/JCO.2011.40.6272","article-title":"Addition of rituximab to chlorambucil produces superior event-free survival in the treatment of patients with extranodal marginal-zone B-cell lymphoma: 5-year analysis of the IELSG-19 Randomized Study","volume":"31","author":"Zucca","year":"2013","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.semcancer.2013.09.004_bib0280","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3201\/eid0204.960406","article-title":"Chlamydiae as pathogens: new species and new issues","volume":"2","author":"Peeling","year":"1996","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"10.1016\/j.semcancer.2013.09.004_bib0285","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/nrmicro1007","article-title":"Chlamydia and apoptosis: life and death decisions of an intracellular pathogen","volume":"2","author":"Byrne","year":"2004","journal-title":"Nat Rev Microbiol"},{"issue":"3-4","key":"10.1016\/j.semcancer.2013.09.004_bib0290","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.vetmic.2012.01.002","article-title":"More than classical Chlamydia psittaci in urban pigeons","volume":"157","author":"Sachse","year":"2012","journal-title":"Vet Microbiol"},{"issue":"2","key":"10.1016\/j.semcancer.2013.09.004_bib0295","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/003655499750006164","article-title":"Chlamydial antibodies in an elderly Finnish population","volume":"31","author":"Koivisto","year":"1999","journal-title":"Scand J Infect Dis"},{"issue":"1","key":"10.1016\/j.semcancer.2013.09.004_bib0300","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/annonc\/mdm561","article-title":"Chlamydia psittaci-eradicating antibiotic therapy in patients with advanced-stage ocular adnexal MALT lymphoma","volume":"19","author":"Ferreri","year":"2008","journal-title":"Ann Oncol"},{"issue":"18","key":"10.1016\/j.semcancer.2013.09.004_bib0305","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1158\/1078-0432.CCR-08-0676","article-title":"Chlamydia infection and lymphomas: association beyond ocular adnexal lymphomas highlighted by multiple detection methods","volume":"14","author":"Ponzoni","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"13","key":"10.1016\/j.semcancer.2013.09.004_bib0310","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/jnci\/djj248","article-title":"Rapidly increasing incidence of ocular non-Hodgkin lymphoma","volume":"98","author":"Moslehi","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.semcancer.2013.09.004_bib0315","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/ijc.23596","article-title":"Chlamydophila psittaci is viable and infectious in the conjunctiva and peripheral blood of patients with ocular adnexal lymphoma: results of a single-center prospective case-control study","volume":"123","author":"Ferreri","year":"2008","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.semcancer.2013.09.004_bib0320","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/annonc\/mdm513","article-title":"Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy","volume":"19","author":"Ferreri","year":"2008","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.semcancer.2013.09.004_bib0325","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/modpathol.3880366","article-title":"Clinical, histopathological, and immunogenetic analysis of ocular adnexal lymphoproliferative disorders: characterization of malt lymphoma and reactive lymphoid hyperplasia","volume":"14","author":"Mannami","year":"2001","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.semcancer.2013.09.004_bib0330","first-page":"555","article-title":"Immunoglobulin VH gene expression among extranodal marginal zone B-cell lymphomas of the ocular adnexa","volume":"40","author":"Coupland","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"10.1016\/j.semcancer.2013.09.004_bib0335","first-page":"2450","article-title":"Immunoglobulin heavy chain gene analysis of ocular adnexal extranodal marginal zone B-cell lymphoma","volume":"42","author":"Hara","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.semcancer.2013.09.004_bib0340","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0002-9440(10)64157-0","article-title":"Mucosa-associated lymphoid tissue lymphomas with t(11;18)(q21;q21) and mucosa-associated lymphoid tissue lymphomas with aneuploidy develop along different pathogenetic pathways","volume":"161","author":"Remstein","year":"2002","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.semcancer.2013.09.004_bib0345","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1158\/1078-0432.CCR-0873-03","article-title":"Frequency of chromosomal aberrations involving MALT1 in mucosa-associated lymphoid tissue lymphoma in patients with Sjogren's syndrome","volume":"10","author":"Streubel","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.semcancer.2013.09.004_bib0350","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1365-2141.2011.08946.x","article-title":"Integrated DNA copy number and methylation profiling of lymphoid neoplasms using a single array","volume":"156","author":"Kwee","year":"2012","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.semcancer.2013.09.004_bib0355","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/path.2466","article-title":"A20 deletion is associated with copy number gain at the TNFA\/B\/C locus and occurs preferentially in translocation-negative MALT lymphoma of the ocular adnexa and salivary glands","volume":"217","author":"Chanudet","year":"2009","journal-title":"J Pathol"},{"issue":"4","key":"10.1016\/j.semcancer.2013.09.004_bib0360","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/leu.2011.276","article-title":"Immunoglobulin gene repertoire in ocular adnexal lymphomas: hints on the nature of the antigenic stimulation","volume":"26","author":"Dagklis","year":"2012","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.semcancer.2013.09.004_bib0365","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1038\/leu.2012.28","article-title":"Chlamydia psittaci-negative ocular adnexal marginal zone B-cell lymphomas have biased VH4-34 immunoglobulin gene expression and proliferate in a distinct inflammatory environment","volume":"26","author":"van Maldegem","year":"2012","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.semcancer.2013.09.004_bib0370","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0360-3016(02)04159-7","article-title":"Outcome and prognostic factors in orbital lymphoma: a Rare Cancer Network study on 90 consecutive patients treated with radiotherapy","volume":"55","author":"Martinet","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.semcancer.2013.09.004_bib0375","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1182\/blood-2005-06-2332","article-title":"Ocular adnexal lymphoma: a clinicopathological study of a large cohort of patients with no evidence for an association with Chlamydia psittaci","volume":"107","author":"Rosado","year":"2005","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.semcancer.2013.09.004_bib0380","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.ophtha.2003.09.049","article-title":"Long-term follow-up results of observation or radiation for conjunctival malignant lymphoma","volume":"111","author":"Matsuo","year":"2004","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.semcancer.2013.09.004_bib0385","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/annonc\/mdj025","article-title":"Long-term follow-up results of no initial therapy for ocular adnexal MALT lymphoma","volume":"17","author":"Tanimoto","year":"2006","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.semcancer.2013.09.004_bib0390","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.radonc.2005.11.005","article-title":"Ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy","volume":"78","author":"Ejima","year":"2006","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.semcancer.2013.09.004_bib0395","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/hon.743","article-title":"Radiation therapy for localized low-grade non-Hodgkin's lymphomas","volume":"23","author":"Tsang","year":"2005","journal-title":"Hematol Oncol"},{"issue":"7","key":"10.1016\/j.semcancer.2013.09.004_bib0400","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.ophtha.2006.01.057","article-title":"Oral chlorambucil for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue of the orbit","volume":"113","author":"Ben Simon","year":"2006","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.semcancer.2013.09.004_bib0405","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/028418601750288217","article-title":"Non-Hodgkin's lymphoma of the ocular adnexa","volume":"40","author":"Sasai","year":"2001","journal-title":"Acta Oncol"},{"issue":"11","key":"10.1016\/j.semcancer.2013.09.004_bib0410","first-page":"1578","article-title":"Rituximab in patients with mucosal-associated lymphoid tissue-type lymphoma of the ocular adnexa","volume":"90","author":"Ferreri","year":"2005","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.semcancer.2013.09.004_bib0415","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0161-6420(00)00591-1","article-title":"Local chemotherapy with interferon-alpha for conjunctival mucosa-associated lymphoid tissue lymphoma: a preliminary report","volume":"108","author":"Blasi","year":"2001","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.semcancer.2013.09.004_bib0420","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ophtha.2010.04.036","article-title":"Intralesional rituximab: a new therapeutic approach for patients with conjunctival lymphomas","volume":"118","author":"Ferreri","year":"2011","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.semcancer.2013.09.004_bib0425","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/bjc.2012.2","article-title":"Exposure to animals and increased risk of marginal zone B-cell lymphomas of the ocular adnexae","volume":"106","author":"Dolcetti","year":"2012","journal-title":"Br J Cancer"},{"issue":"9","key":"10.1016\/j.semcancer.2013.09.004_bib0430","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/ajh.20962","article-title":"Chlamydia psittaci infection and clinicopathologic analysis of ocular adnexal lymphomas in Korea","volume":"82","author":"Yoo","year":"2007","journal-title":"Am J Hematol"},{"issue":"8","key":"10.1016\/j.semcancer.2013.09.004_bib0435","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.leukres.2007.10.013","article-title":"Chlamydia psittaci in MALT lymphomas of ocular adnexals: the Austrian experience","volume":"32","author":"Aigelsreiter","year":"2008","journal-title":"Leuk Res"},{"issue":"3","key":"10.1016\/j.semcancer.2013.09.004_bib0440","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/path.1984","article-title":"Chlamydia psittaci is variably associated with ocular adnexal MALT lymphoma in different geographical regions","volume":"209","author":"Chanudet","year":"2006","journal-title":"J Pathol"},{"issue":"3","key":"10.1016\/j.semcancer.2013.09.004_bib0445","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1086\/338569","article-title":"Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines","volume":"185","author":"Smith","year":"2002","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.semcancer.2013.09.004_bib0450","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.mib.2005.12.004","article-title":"Chlamydia and programmed cell death","volume":"9","author":"Miyairi","year":"2006","journal-title":"Curr Opin Microbiol"},{"issue":"1","key":"10.1016\/j.semcancer.2013.09.004_bib0455","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00003226-200401000-00012","article-title":"Combination of adult inclusion conjunctivitis and mucosa-associated lymphoid tissue (MALT) lymphoma in a young adult","volume":"23","author":"Yeung","year":"2004","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.semcancer.2013.09.004_bib0460","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0021-9150(02)00301-5","article-title":"Molecular mimicry in atherosclerosis: a role for heat shock proteins in immunisation","volume":"167","author":"Lamb","year":"2003","journal-title":"Atherosclerosis"},{"issue":"13","key":"10.1016\/j.semcancer.2013.09.004_bib0465","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1096\/fasebj.12.13.1255","article-title":"Molecular mimicry and immune-mediated diseases","volume":"12","author":"Oldstone","year":"1998","journal-title":"FASEB J"},{"issue":"9382","key":"10.1016\/j.semcancer.2013.09.004_bib0470","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0140-6736(03)14075-5","article-title":"Heat shock proteins as regulators of the immune response","volume":"362","author":"Pockley","year":"2003","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.semcancer.2013.09.004_bib0475","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1128\/CDLI.8.6.1056-1059.2001","article-title":"Immunoglobulin G1 antibody response to Helicobacter pylori heat shock protein 60 is closely associated with low-grade gastric mucosa-associated lymphoid tissue lymphoma","volume":"8","author":"Ishii","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"issue":"11","key":"10.1016\/j.semcancer.2013.09.004_bib0480","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1093\/annonc\/mdl124","article-title":"Bacteria-eradicating therapy for ocular adnexal MALT lymphoma: questions for an open international prospective trial","volume":"17","author":"Ferreri","year":"2006","journal-title":"Ann Oncol"},{"issue":"24","key":"10.1016\/j.semcancer.2013.09.004_bib0485","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1200\/JCO.2011.41.4466","article-title":"Chlamydophila psittaci eradication with doxycycline as first-line targeted therapy for ocular adnexae lymphoma: final results of an international phase II trial","volume":"30","author":"Ferreri","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semcancer.2013.09.004_bib0490","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/annonc\/mdm513","article-title":"Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy","volume":"19","author":"Ferreri","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.semcancer.2013.09.004_bib0495","first-page":"62","article-title":"Detection of Helicobacter pylori and Chlamydia pneumoniae genes in primary orbital lymphoma","volume":"104","author":"Chan","year":"2006","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"1","key":"10.1016\/j.semcancer.2013.09.004_bib0500","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ophtha.2006.09.020","article-title":"Role of Helicobacter pylori in conjunctival mucosa-associated lymphoid tissue lymphoma","volume":"114","author":"Sjo","year":"2007","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.semcancer.2013.09.004_bib0505","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/bjo.2007.132316","article-title":"The association between conjunctival MALT lymphoma and Helicobacter pylori","volume":"92","author":"Lee","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.semcancer.2013.09.004_bib0510","article-title":"Chlamydia psittaci, Helicobacter pylori and ocular adnexal lymphoma-is there an association? The German experience","volume":"24","author":"Goebel","year":"2007","journal-title":"Leuk Res"},{"issue":"4","key":"10.1016\/j.semcancer.2013.09.004_bib0515","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/bjo.2007.134965","article-title":"Ocular adnexal lymphoma. What is the evidence for an infectious aetiology?","volume":"92","author":"Cohen","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.semcancer.2013.09.004_bib0520","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/annonc\/mdl388","article-title":"Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT","volume":"18","author":"Arcaini","year":"2007","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.semcancer.2013.09.004_bib0525","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1309\/AJCPXMDRT1SY6KIV","article-title":"Chlamydia psittaci infection in nongastrointestinal extranodal MALT lymphomas and their precursor lesions","volume":"135","author":"Aigelsreiter","year":"2011","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"10.1016\/j.semcancer.2013.09.004_bib0530","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/sj.bjc.6603981","article-title":"Chlamydiae and Mycoplasma infections in pulmonary MALT lymphoma","volume":"97","author":"Chanudet","year":"2007","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.semcancer.2013.09.004_bib0535","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/(SICI)1099-1069(199909)17:3<107::AID-HON644>3.0.CO;2-R","article-title":"Positive serology for Lyme disease borrelias in primary cutaneous B-cell lymphoma: a study in 22 patients; is it a fortuitous finding?","volume":"17","author":"Jelic","year":"1999","journal-title":"Hematol Oncol"},{"issue":"4","key":"10.1016\/j.semcancer.2013.09.004_bib0540","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/0190-9622(91)70088-J","article-title":"Borrelia burgdorferi-associated cutaneous B cell lymphoma: clinical and immunohistologic characterization of four cases","volume":"24","author":"Garbe","year":"1991","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.semcancer.2013.09.004_bib0545","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1365-2559.2000.01003.x","article-title":"Borrelia burgdorferi-associated cutaneous marginal zone lymphoma: a clinicopathological study of two cases illustrating the temporal progression of B. burgdorferi-associated B-cell proliferation in the skin","volume":"37","author":"Goodlad","year":"2000","journal-title":"Histopathology"},{"issue":"8","key":"10.1016\/j.semcancer.2013.09.004_bib0550","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1600-0560.1997.tb01318.x","article-title":"Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma","volume":"24","author":"Cerroni","year":"1997","journal-title":"J Cutan Pathol"},{"issue":"4","key":"10.1016\/j.semcancer.2013.09.004_bib0555","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1067\/mjd.2002.120475","article-title":"Borrelia burgdorferi-associated lymphocytoma cutis simulating a primary cutaneous large B-cell lymphoma","volume":"47","author":"Grange","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.semcancer.2013.09.004_bib0560","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1182\/blood-2005-09-3679","article-title":"Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation","volume":"107","author":"Suarez","year":"2006","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.semcancer.2013.09.004_bib0565","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/00000478-200305000-00017","article-title":"Borrelia-associated primary cutaneous MALT lymphoma in a nonendemic region","volume":"27","author":"de la Fouchardiere","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.semcancer.2013.09.004_bib0570","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1634\/theoncologist.2011-0108","article-title":"Prevalence of Borrelia burgdorferi infection in a series of 98 primary cutaneous lymphomas","volume":"16","author":"Ponzoni","year":"2011","journal-title":"Oncologist"},{"issue":"9","key":"10.1016\/j.semcancer.2013.09.004_bib0575","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/modpathol.3800400","article-title":"p16\/INK4a gene methylation is a frequent finding in pulmonary MALT lymphomas at diagnosis","volume":"18","author":"Takino","year":"2005","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1016\/j.semcancer.2013.09.004_bib0580","doi-asserted-by":"crossref","first-page":"5524","DOI":"10.1182\/blood-2007-08-109611","article-title":"Borrelia infection and risk of non-Hodgkin lymphoma","volume":"111","author":"Schollkopf","year":"2008","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.semcancer.2013.09.004_bib0585","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/sj.bjc.6602997","article-title":"Mycosis fungoides: is it a Borrelia burgdorferi-associated disease?","volume":"94","author":"Tothova","year":"2006","journal-title":"Br J Cancer"},{"issue":"10","key":"10.1016\/j.semcancer.2013.09.004_bib0590","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1034\/j.1600-0560.2001.281002.x","article-title":"Absence of Borrelia burgdorferi DNA in cutaneous B-cell lymphomas from the United States","volume":"28","author":"Wood","year":"2001","journal-title":"J Cutan Pathol"},{"issue":"11","key":"10.1016\/j.semcancer.2013.09.004_bib0595","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1080\/10428190701618250","article-title":"Clinicopathological features of primary cutaneous B-cell lymphomas from an academic regional hospital in central Italy: no evidence of Borrelia burgdorferi association","volume":"48","author":"Goteri","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.semcancer.2013.09.004_bib0600","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0190-9622(97)80405-7","article-title":"Borrelia burgdorferi-associated primary cutaneous B cell lymphoma: complete clearing of skin lesions after antibiotic pulse therapy or intralesional injection of interferon alfa-2a","volume":"36","author":"Kutting","year":"1997","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.semcancer.2013.09.004_bib0605","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0046-8177(00)80233-6","article-title":"Eradication of Borrelia burgdorferi infection in primary marginal zone B-cell lymphoma of the skin","volume":"31","author":"Roggero","year":"2000","journal-title":"Hum Pathol"},{"issue":"10","key":"10.1016\/j.semcancer.2013.09.004_bib0610","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.semcancer.2013.09.004_bib0615","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1200\/JCO.1996.14.2.549","article-title":"Treatment of primary cutaneous B-cell lymphomas of follicle center cell origin: a clinical follow-up study of 55 patients treated with radiotherapy or polychemotherapy","volume":"14","author":"Rijlaarsdam","year":"1996","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.semcancer.2013.09.004_bib0620","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1182\/blood.V99.3.800","article-title":"Primary cutaneous lymphomas: applicability of current classification schemes (European Organization for Research and Treatment of Cancer, World Health Organization) based on clinicopathologic features observed in a large group of patients","volume":"99","author":"Fink-Puches","year":"2002","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.semcancer.2013.09.004_bib0625","doi-asserted-by":"crossref","first-page":"468","DOI":"10.2350\/06-01-0006.1","article-title":"Primary cutaneous marginal zone B-cell lymphoma of MALT type in a child","volume":"9","author":"Dargent","year":"2006","journal-title":"Pediatr Dev Pathol"},{"issue":"10","key":"10.1016\/j.semcancer.2013.09.004_bib0630","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1080\/10428190600774873","article-title":"Thoughts on the eradication of Helicobacter pylori infection in localized gastric mucosa-associated lymphoid tissue lymphoma","volume":"47","author":"Zinzani","year":"2006","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"10.1016\/j.semcancer.2013.09.004_bib0635","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.annder.2008.07.057","article-title":"Marginal zone B-cell lymphoma affecting the skin: histological and phenotypic study of 49 cases","volume":"135","author":"Bathelier","year":"2008","journal-title":"Ann Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.semcancer.2013.09.004_bib0640","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1046\/j.1365-2133.2002.04961.x","article-title":"Primary cutaneous marginal zone B-cell lymphoma: a clinical, histopathological, immunophenotypic and molecular genetic study of 22 cases","volume":"147","author":"Servitje","year":"2002","journal-title":"Br J Dermatol"},{"issue":"Suppl","key":"10.1016\/j.semcancer.2013.09.004_bib0645","first-page":"S38","article-title":"Primary cutaneous marginal zone B-cell lymphoma","volume":"125","author":"Cho-Vega","year":"2006","journal-title":"Am J Clin Pathol"},{"issue":"9","key":"10.1016\/j.semcancer.2013.09.004_bib0650","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1001\/archderm.141.9.1139","article-title":"Primary cutaneous marginal zone B-cell lymphoma: clinical and therapeutic features in 50 cases","volume":"141","author":"Hoefnagel","year":"2005","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.semcancer.2013.09.004_bib0655","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/00000478-200106000-00004","article-title":"Cutaneous b-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification","volume":"25","author":"de Leval","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.semcancer.2013.09.004_bib0660","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1182\/blood-2008-01-132415","article-title":"The majority of cutaneous marginal zone B-cell lymphomas expresses class-switched immunoglobulins and develops in a T-helper type 2 inflammatory environment","volume":"112","author":"van Maldegem","year":"2008","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.semcancer.2013.09.004_bib0665","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.humpath.2006.02.012","article-title":"Aberrant nuclear BCL10 expression and lack of t(11;18)(q21;q21) in primary cutaneous marginal zone B-cell lymphoma","volume":"37","author":"Gallardo","year":"2006","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.semcancer.2013.09.004_bib0670","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1365-2133.2009.09576.x","article-title":"Primary cutaneous B-cell lymphoma is associated with somatically hypermutated immunoglobulin variable genes and frequent use of VH1-69 and VH4-59 segments","volume":"162","author":"Perez","year":"2010","journal-title":"Br J Dermatol"},{"issue":"March (6)","key":"10.1016\/j.semcancer.2013.09.004_bib0675","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1182\/blood-2002-09-2963","article-title":"T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma","volume":"101","author":"Streubel","year":"2003","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.semcancer.2013.09.004_bib0680","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/path.2372","article-title":"Distinct signatures of B-cell homeostatic and activation-dependent chemokine receptors in the development and progression of extragastric MALT lymphomas","volume":"215","author":"Deutsch","year":"2008","journal-title":"J Pathol"},{"issue":"1","key":"10.1016\/j.semcancer.2013.09.004_bib0685","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.0022-202X.2004.22720.x","article-title":"Molecular cytogenetic analysis of chromosomal breakpoints in the IGH, MYC, BCL6, and MALT1 gene loci in primary cutaneous B-cell lymphomas","volume":"123","author":"Hallermann","year":"2004","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.semcancer.2013.09.004_bib0690","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1182\/blood-2008-04-152850","article-title":"European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas","volume":"112","author":"Senff","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.semcancer.2013.09.004_bib0695","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/1523-1747.ep12285646","article-title":"Molecular subtyping of Borrelia burgdorferi sensu lato isolates from five patients with solitary lymphocytoma","volume":"108","author":"Picken","year":"1997","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1016\/j.semcancer.2013.09.004_bib0700","first-page":"356","article-title":"Borrelia infections of the skin-progress of knowledge since the discovery of Lyme disease","volume":"42","author":"Garbe","year":"1991","journal-title":"Hautarzt"},{"issue":"3","key":"10.1016\/j.semcancer.2013.09.004_bib0705","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000106580","article-title":"Borrelia burgdorferi-associated primary cutaneous marginal-zone B-cell lymphoma: a case report","volume":"215","author":"Monari","year":"2007","journal-title":"Dermatology"},{"issue":"1","key":"10.1016\/j.semcancer.2013.09.004_bib0710","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s001050050005","article-title":"Therapy of primary cutaneous B-cell lymphomas","volume":"51","author":"Zenahlik","year":"2000","journal-title":"Hautarzt"},{"issue":"5","key":"10.1016\/j.semcancer.2013.09.004_bib0715","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1080\/10428190500399698","article-title":"Intra-lesional low-dose interferon alpha2a therapy for primary cutaneous marginal zone B-cell lymphoma","volume":"47","author":"Cozzio","year":"2006","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1016\/j.semcancer.2013.09.004_bib0720","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2302\/kjm.50.269","article-title":"Diagnostic criteria of primary cutaneous B-cell lymphomas and pseudolymphomas","volume":"50","author":"Kerl","year":"2001","journal-title":"Keio J Med"},{"issue":"8","key":"10.1016\/j.semcancer.2013.09.004_bib0725","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1182\/blood-2002-11-3496","article-title":"Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type","volume":"102","author":"Conconi","year":"2003","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.semcancer.2013.09.004_bib0730","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/annonc\/mdn636","article-title":"Rituximab monotherapy for primary cutaneous B-cell lymphoma: response and follow-up in 16 patients","volume":"20","author":"Valencak","year":"2009","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.semcancer.2013.09.004_bib0735","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1128\/JCM.39.9.3346-3349.2001","article-title":"Sequence typing confirms that Campylobacter jejuni strains associated with Guillain\u2013Barre and Miller\u2013Fisher syndromes are of diverse genetic lineage, serotype, and flagella type","volume":"39","author":"Dingle","year":"2001","journal-title":"J Clin Microbiol"},{"issue":"12","key":"10.1016\/j.semcancer.2013.09.004_bib0740","doi-asserted-by":"crossref","first-page":"7409","DOI":"10.1128\/AEM.69.12.7409-7413.2003","article-title":"Genetic diversity of Campylobacter jejuni isolates from farm animals and the farm environment","volume":"69","author":"Colles","year":"2003","journal-title":"Appl Environ Microbiol"},{"issue":"4","key":"10.1016\/j.semcancer.2013.09.004_bib0745","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.exppara.2007.10.014","article-title":"Prevalence of Cryptosporidium and Giardia species in animals in irrigation catchments in the southwest of Australia","volume":"118","author":"McCarthy","year":"2008","journal-title":"Exp Parasitol"},{"issue":"4","key":"10.1016\/j.semcancer.2013.09.004_bib0750","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijmm.2009.07.002","article-title":"Campylobacter jejuni: a brief overview on pathogenicity-associated factors and disease-mediating mechanisms","volume":"300","author":"Dasti","year":"2010","journal-title":"Int J Med Microbiol"},{"issue":"July (2)","key":"10.1016\/j.semcancer.2013.09.004_bib0755","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1086\/322010","article-title":"Absence of clonality of Campylobacter jejuni in serotypes other than HS:19 associated with Guillain\u2013Barre syndrome and gastroenteritis","volume":"184","author":"Engberg","year":"2001","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.semcancer.2013.09.004_bib0760","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1051\/vetres:2005012","article-title":"Campylobacter","volume":"36","author":"Moore","year":"2005","journal-title":"Vet Res"},{"issue":"9","key":"10.1016\/j.semcancer.2013.09.004_bib0765","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.dld.2012.03.020","article-title":"Immunoproliferative small intestinal disease associated with Campylobacter jejuni","volume":"44","author":"Mesnard","year":"2012","journal-title":"Dig Liver Dis"},{"issue":"1","key":"10.1016\/j.semcancer.2013.09.004_bib0770","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/bjs.1800810107","article-title":"Immunoproliferative small intestinal disease: mediterranean lymphoma and alpha heavy chain disease","volume":"81","author":"Martin","year":"1994","journal-title":"Br J Surg"},{"issue":"2\u20133","key":"10.1016\/j.semcancer.2013.09.004_bib0775","first-page":"239","article-title":"Immunoproliferative small intestinal disease (IPSID): relationships with alpha-chain disease and Mediterranean lymphomas","volume":"12","author":"Rambaud","year":"1990","journal-title":"Semin Immunopathol (Springer)"},{"key":"10.1016\/j.semcancer.2013.09.004_bib0780","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1056\/NEJMoa031887","article-title":"Immunoproliferative small intestinal disease associated with Campylobacter jejuni","volume":"350","author":"Lecuit","year":"2004","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.semcancer.2013.09.004_bib0785","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/ajh.2830410312","article-title":"Leukemic manifestation in a case of alpha-chain disease with multiple polypoid intestinal lymphocytic lymphoma","volume":"41","author":"Chang","year":"1992","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.semcancer.2013.09.004_bib0790","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/mpo.2950160213","article-title":"Clinical and pathological evolution of alpha chain disease to immunoblastic lymphoma and response to COMP chemotherapy","volume":"16","author":"Rogers","year":"1988","journal-title":"Med Pediatr Oncol"},{"issue":"6","key":"10.1016\/j.semcancer.2013.09.004_bib0795","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1182\/blood-2004-07-2755","article-title":"Immunoproliferative small intestinal disease (IPSID): a model for mature B-cell neoplasms","volume":"105","author":"Al-Saleem","year":"2005","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.semcancer.2013.09.004_bib0800","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/(SICI)1097-0142(19970701)80:1<8::AID-CNCR2>3.0.CO;2-T","article-title":"Five-year results of the treatment of 23 patients with immunoproliferative small intestinal disease: a Turkish experience","volume":"80","author":"Akbulut","year":"1997","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.semcancer.2013.09.004_bib0805","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1111\/j.1572-0241.2000.03318.x","article-title":"Should we suppress the antigenic stimulus in IPSID for lifelong?","volume":"95","author":"Celik","year":"2000","journal-title":"Am J Gastroenterol"},{"issue":"April (16)","key":"10.1016\/j.semcancer.2013.09.004_bib0810","first-page":"1685","article-title":"Immunoproliferative small intestinal disease associated with Campylobacter jejuni","volume":"350","author":"Peterson","year":"2004","journal-title":"N Engl J Med"},{"issue":"8092 Pt 1","key":"10.1016\/j.semcancer.2013.09.004_bib0815","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(78)92705-8","article-title":"Evidence of acquired immune deficiencies in Mediterranean lymphoma. A possible aetiological link","volume":"2","author":"Al-Saleem","year":"1978","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.semcancer.2013.09.004_bib0820","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2000-9506","article-title":"Epidemiology of hepatitis C: geographic differences and temporal trends","volume":"20","author":"Wasley","year":"2000","journal-title":"Semin Liver Dis"},{"issue":"9","key":"10.1016\/j.semcancer.2013.09.004_bib0825","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S1473-3099(05)70216-4","article-title":"Global epidemiology of hepatitis C virus infection","volume":"5","author":"Shepard","year":"2005","journal-title":"Lancet Infect Dis"},{"issue":"February (6)","key":"10.1016\/j.semcancer.2013.09.004_bib0830","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1182\/blood-2010-06-275818","article-title":"Hepatitis viruses and non-Hodgkin lymphoma: epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities","volume":"117","author":"Marcucci","year":"2011","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.semcancer.2013.09.004_bib0835","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1053\/j.gastro.2003.09.025","article-title":"Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis","volume":"125","author":"Gisbert","year":"2003","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.semcancer.2013.09.004_bib0840","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1053\/j.gastro.2006.09.019","article-title":"Hepatitis C and risk of lymphoma: results of the European multicenter case-control study EPILYMPH","volume":"131","author":"Nieters","year":"2006","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.semcancer.2013.09.004_bib0845","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cgh.2008.02.011","article-title":"Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium","volume":"6","author":"de Sanjose","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.semcancer.2013.09.004_bib0850","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1046\/j.1365-2141.1996.d01-1791.x","article-title":"Additional neoplasms and HCV infection in low-grade lymphoma of MALT type","volume":"94","author":"Luppi","year":"1996","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.semcancer.2013.09.004_bib0855","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/annonc\/mdp454","article-title":"Subcutaneous \u2018lipoma-like\u2019 B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT","volume":"21","author":"Paulli","year":"2010","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.semcancer.2013.09.004_bib0860","first-page":"495","article-title":"Triple association between hepatitis C virus infection, systemic autoimmune diseases, and B cell lymphoma","volume":"31","author":"Ramos-Casals","year":"2004","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.semcancer.2013.09.004_bib0865","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/annonc\/mdl027","article-title":"Clinical implications of hepatitis C virus infection in MALT-type lymphoma of the ocular adnexa","volume":"17","author":"Ferreri","year":"2006","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.semcancer.2013.09.004_bib0870","first-page":"80","article-title":"Marginal zone-related neoplasms of splenic and nodal origin","volume":"88","author":"Arcaini","year":"2003","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.semcancer.2013.09.004_bib0875","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1002\/art.21270","article-title":"Involvement of chemokines and type 1 cytokines in the pathogenesis of hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy","volume":"52","author":"Saadoun","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.semcancer.2013.09.004_bib0880","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1136\/jcp.40.6.642","article-title":"B cell lymphoma with circulating villous lymphocytes: differential diagnosis of B cell leukaemias with large spleens","volume":"40","author":"Melo","year":"1987","journal-title":"J Clin Pathol"},{"issue":"11","key":"10.1016\/j.semcancer.2013.09.004_bib0885","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1182\/blood.V84.11.3828.bloodjournal84113828","article-title":"The histopathology of splenic lymphoma with villous lymphocytes","volume":"84","author":"Isaacson","year":"1994","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.semcancer.2013.09.004_bib0890","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1046\/j.1365-2141.2003.04165.x","article-title":"Prognostic features of splenic lymphoma with villous lymphocytes: a report on 129 patients","volume":"120","author":"Parry-Jones","year":"2003","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.semcancer.2013.09.004_bib0895","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/bjh.12011","article-title":"Risk stratification for splenic marginal zone lymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: development and validation on 593 cases","volume":"159","author":"Montalban","year":"2012","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.semcancer.2013.09.004_bib0900","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3816\/CLM.2002.n.010","article-title":"Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients","volume":"3","author":"Thieblemont","year":"2002","journal-title":"Clin Lymphoma"},{"issue":"3","key":"10.1016\/j.semcancer.2013.09.004_bib0905","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1600-0609.2009.01301.x","article-title":"Nodal marginal zone lymphoma: current knowledge and future directions of an heterogeneous disease","volume":"83","author":"Arcaini","year":"2009","journal-title":"Eur J Haematol"},{"issue":"3","key":"10.1016\/j.semcancer.2013.09.004_bib0910","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1200\/JCO.2005.06.008","article-title":"Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience","volume":"23","author":"Vallisa","year":"2005","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.semcancer.2013.09.004_bib0915","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1111\/j.1365-2893.2011.01515.x","article-title":"Peginterferon alfa-2b plus weight-based ribavirin for 24 weeks in patients with chronic hepatitis C virus genotype 1 with low viral load who achieve rapid viral response","volume":"19","author":"Craxi","year":"2012","journal-title":"J Viral Hepat"},{"issue":"2","key":"10.1016\/j.semcancer.2013.09.004_bib0920","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJMoa013376","article-title":"Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection","volume":"347","author":"Hermine","year":"2002","journal-title":"N Engl J Med"},{"issue":"Suppl. 4","key":"10.1016\/j.semcancer.2013.09.004_bib0925","first-page":"138","article-title":"Hematological response to antiviral treatment in 94 patients with indolent b-cell lymphomas associated with hepatitis c virus infection: a study of the Fondazione Italiana Linfomi (FIL)","volume":"22","author":"Arcaini","year":"2011","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.semcancer.2013.09.004_bib0930","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1038\/sj.leu.2403443","article-title":"Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas","volume":"18","author":"Kelaidi","year":"2004","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.semcancer.2013.09.004_bib0935","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1365-2141.2008.07565.x","article-title":"Pegylated-interferon plus ribavirin for HCV-positive indolent non-Hodgkin lymphomas","volume":"145","author":"Mazzaro","year":"2009","journal-title":"Br J Haematol"}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X13000990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X13000990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T02:30:29Z","timestamp":1596594629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X13000990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":187,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S1044579X13000990"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2013.09.004","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Marginal zone lymphomas and infectious agents","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2013.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}